May 15 |
Orchestra BioMed reports Q1 results
|
May 13 |
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates
|
May 13 |
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
|
Apr 30 |
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
|
Apr 30 |
Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
|
Mar 29 |
Orchestra BioMed Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
Mar 27 |
Orchestra BioMed reports FY results
|
Mar 27 |
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
|
Mar 26 |
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
|
Mar 13 |
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
|